HR 1614
116th Congress
House
Crime and Law Enforcement
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health personnel
Licensing and registrations
Prescription drugs
John S. McCain Opioid Addiction Prevention Act
Introduced: March 7, 2019
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 12, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Mar 8, 2019
Referred to the Subcommittee on Health.
Mar 7, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 7, 2019
Introduced in House
Plain-English summary
John S. McCain Opioid Addiction Prevention Act
This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV.
Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committees of jurisdiction
4